Veritas Pharma Inc. | Income Statement
Fiscal year is May-April. All values USD Thousands.
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
-
1.10
14.50
Gross Income
-
-
1.10
14.50
SG&A Expense
201.20
656.60
2,541.60
10,229.70
EBIT
-
656.60
2,542.70
10,244.20
Unusual Expense
21.80
-
-
697.20
Non Operating Income/Expense
-
-
330.00
12.90
Interest Expense
-
37.70
25.50
-
Pretax Income
223.00
694.30
2,238.20
10,954.30
Consolidated Net Income
223.00
694.30
2,238.20
10,954.30
Net Income
223.00
694.30
2,224.50
10,845.90
Net Income After Extraordinaries
188.30
506.10
2,224.50
10,845.90
Net Income Available to Common
634.30
796.50
2,224.50
10,845.90
EPS (Basic)
0.03
0.05
0.08
0.23
Basic Shares Outstanding
19,239.70
20,367.40
28,407.10
46,903.80
EPS (Diluted)
0.03
0.04
0.08
0.23
Diluted Shares Outstanding
19,239.70
20,367.40
28,407.10
46,903.80
EBITDA
201.20
656.60
2,541.60
10,229.70
Minority Interest Expense
-
-
13.70
108.40
About Veritas Pharma
View Profile
